# OnCo record nct06601335 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06601335/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06601335", "NCT06601335" ;
  schema:name "A Phase 3 Study of AK112 Plus AK117 Versus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)"@en ;
  schema:description "A phase 3 trial testing AK117 in head and neck squamous cell carcinoma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06601335/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06601335> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-10-30" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/recurrent-metastatic-hnscc/> ;
  onco:drugs <https://onco.cc/drugs/ak117/> ;
  onco:companies <https://onco.cc/companies/akeso/> .